{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:35:25Z","timestamp":1792784125651,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104351"],"award-info":[{"award-number":["82104351"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82361138570"],"award-info":[{"award-number":["82361138570"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhejiang Provincial Traditional Chinese Medicine Science and Technology Project","award":["2024ZF023"],"award-info":[{"award-number":["2024ZF023"]}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LR23H280001"],"award-info":[{"award-number":["LR23H280001"]}],"id":[{"id":"https:\/\/ror.org\/04aqat463","id-type":"ROR","asserted-by":"crossref"}]},{"name":"\u201cPioneer\u201d and \u201cLeading Goose\u201d R&D Program of Zhejiang","award":["2024C03106"],"award-info":[{"award-number":["2024C03106"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M743077"],"award-info":[{"award-number":["2023M743077"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Construction Fund of Key Medical Disciplines of Hangzhou","award":["2025HZZD06"],"award-info":[{"award-number":["2025HZZD06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nat Med"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s11418-025-01939-x","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T12:14:00Z","timestamp":1754741640000},"page":"1122-1139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Discovery of active compounds in Danshen\u2013Chuanxiong formula for blood\u2013brain barrier protection: a multi-parametric study using an OGD\/R-induced spheroid model"],"prefix":"10.1007","volume":"79","author":[{"given":"Yue","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1079-8231","authenticated-orcid":false,"given":"Yule","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"issue":"12","key":"1939_CR1","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nm.3407","volume":"19","author":"B Obermeier","year":"2013","unstructured":"Obermeier B, Daneman R, Ransohoff RM (2013) Development, maintenance and disruption of the blood-brain barrier. Nat Med 19(12):1584\u20131596. https:\/\/doi.org\/10.1038\/nm.3407","journal-title":"Nat Med"},{"issue":"3\u20134","key":"1939_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000499666","volume":"47","author":"Z Nadareishvili","year":"2019","unstructured":"Nadareishvili Z, Simpkins AN, Hitomi E, Reyes D, Leigh R (2019) Post-stroke blood-brain barrier disruption and poor functional outcome in patients receiving thrombolytic therapy. Cerebrovasc Dis 47(3\u20134):135\u2013142. https:\/\/doi.org\/10.1159\/000499666","journal-title":"Cerebrovasc Dis"},{"issue":"3","key":"1939_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV (2018) Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14(3):133\u2013150. https:\/\/doi.org\/10.1038\/nrneurol.2017.188","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1939_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV (2019) Blood-brain barrier: from physiology to disease and back. Physiol Rev 99(1):21\u201378. https:\/\/doi.org\/10.1152\/physrev.00050.2017","journal-title":"Physiol Rev"},{"key":"1939_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.pneurobio.2017.10.001","volume":"163","author":"X Jiang","year":"2018","unstructured":"Jiang X, Andjelkovic AV, Zhu L, Yang T, Bennett MVL, Chen J, Keep RF, Shi Y (2018) Blood-brain barrier dysfunction and recovery after ischemic stroke. Prog Neurobiol 163:144\u2013171. https:\/\/doi.org\/10.1016\/j.pneurobio.2017.10.001","journal-title":"Prog Neurobiol"},{"issue":"2","key":"1939_CR6","doi-asserted-by":"publisher","first-page":"C135","DOI":"10.1152\/ajpcell.00136.2018","volume":"316","author":"C Yang","year":"2019","unstructured":"Yang C, Hawkins KE, Dore S, Candelario-Jalil E (2019) Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. Am J Physiol Cell Physiol 316(2):C135\u2013C153. https:\/\/doi.org\/10.1152\/ajpcell.00136.2018","journal-title":"Am J Physiol Cell Physiol"},{"key":"1939_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.109945","volume":"125","author":"Y Wang","year":"2020","unstructured":"Wang Y, Xiao G, He S, Liu X, Zhu L, Yang X, Zhang Y, Orgah J, Feng Y, Wang X, Zhang B, Zhu Y (2020) Protection against acute cerebral ischemia\/reperfusion injury by QiShenYiQi via neuroinflammatory network mobilization. Biomed Pharmacother 125:109945. https:\/\/doi.org\/10.1016\/j.biopha.2020.109945","journal-title":"Biomed Pharmacother"},{"key":"1939_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.594672","volume":"11","author":"S Bernardo-Castro","year":"2020","unstructured":"Bernardo-Castro S, Sousa JA, Bras A, Cecilia C, Rodrigues B, Almendra L, Machado C, Santo G, Silva F, Ferreira L, Santana I, Sargento-Freitas J (2020) Pathophysiology of blood-brain barrier permeability throughout the different stages of ischemic stroke and its implication on hemorrhagic transformation and recovery. Front Neurol 11:594672. https:\/\/doi.org\/10.3389\/fneur.2020.594672","journal-title":"Front Neurol"},{"issue":"1","key":"1939_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.31083\/j.jin2101026","volume":"21","author":"M Xu","year":"2022","unstructured":"Xu M, Wu RX, Li XL, Zeng YS, Liang JY, Fu K, Liang Y, Wang Z (2022) Traditional medicine in China for ischemic stroke: bioactive components, pharmacology, and mechanisms. J Integr Neurosci 21(1):26. https:\/\/doi.org\/10.31083\/j.jin2101026","journal-title":"J Integr Neurosci"},{"issue":"3","key":"1939_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S1875-5364(15)30002-9","volume":"13","author":"CY Su","year":"2015","unstructured":"Su CY, Ming QL, Rahman K, Han T, Qin LP (2015) Salvia miltiorrhiza: traditional medicinal uses, chemistry, and pharmacology. Chin J Nat Med 13(3):163\u2013182. https:\/\/doi.org\/10.1016\/S1875-5364(15)30002-9","journal-title":"Chin J Nat Med"},{"key":"1939_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.fct.2018.02.050","volume":"119","author":"Z Chen","year":"2018","unstructured":"Chen Z, Zhang C, Gao F, Fu Q, Fu C, He Y, Zhang J (2018) A systematic review on the rhizome of Ligusticum chuanxiong Hort. (Chuanxiong). Food Chem Toxicol 119:309\u2013325. https:\/\/doi.org\/10.1016\/j.fct.2018.02.050","journal-title":"Food Chem Toxicol"},{"key":"1939_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155725","volume":"130","author":"C Yin","year":"2024","unstructured":"Yin C, Zhang M, Jin S, Zhou Y, Ding L, Lv Q, Huang Z, Zhou J, Chen J, Wang P, Zhang S, You Q (2024) Mechanism of Salvia miltiorrhiza Bunge extract to alleviate chronic sleep deprivation-induced cognitive dysfunction in rats. Phytomedicine 130:155725. https:\/\/doi.org\/10.1016\/j.phymed.2024.155725","journal-title":"Phytomedicine"},{"key":"1939_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.666790","volume":"12","author":"B Yu","year":"2021","unstructured":"Yu B, Yao Y, Zhang X, Ruan M, Zhang Z, Xu L, Liang T, Lu J (2021) Synergic neuroprotection between Ligusticum chuanxiong Hort and borneol against ischemic stroke by neurogenesis via modulating reactive astrogliosis and maintaining the blood-brain barrier. Front Pharmacol 12:666790. https:\/\/doi.org\/10.3389\/fphar.2021.666790","journal-title":"Front Pharmacol"},{"key":"1939_CR14","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.2147\/DDDT.S479881","volume":"18","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li Y, Zhou Y, Gao Y, Zhao L (2024) Guanxinning tablet alleviates post-ischemic stroke injury via regulating complement and coagulation cascades pathway and inflammatory network mobilization. Drug Des Devel Ther 18:4183\u20134202. https:\/\/doi.org\/10.2147\/DDDT.S479881","journal-title":"Drug Des Devel Ther"},{"issue":"11","key":"1939_CR15","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.19540\/j.cnki.cjcmm.20220322.402","volume":"47","author":"XR Hui","year":"2022","unstructured":"Hui XR, Jin Q, He JM, Liu L, Zhao XP (2022) Mechanism of Guanxinning against cerebral ischemia-reperfusion injury in mice based on transcriptomic analysis. Zhongguo Zhong Yao Za Zhi 47(11):3015\u20133022. https:\/\/doi.org\/10.19540\/j.cnki.cjcmm.20220322.402","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"1939_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105460","volume":"165","author":"G Xiao","year":"2021","unstructured":"Xiao G, Lyu M, Li Z, Cao L, Liu X, Wang Y, He S, Chen Z, Du H, Feng Y, Wang J, Zhu Y (2021) Restoration of early deficiency of axonal guidance signaling by guanxinning injection as a novel therapeutic option for acute ischemic stroke. Pharmacol Res 165:105460. https:\/\/doi.org\/10.1016\/j.phrs.2021.105460","journal-title":"Pharmacol Res"},{"issue":"9","key":"1939_CR17","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1007\/s13346-023-01327-6","volume":"13","author":"TS Biju","year":"2023","unstructured":"Biju TS, Priya VV, Francis AP (2023) Role of three-dimensional cell culture in therapeutics and diagnostics: an updated review. Drug Deliv Transl Res 13(9):2239\u20132253. https:\/\/doi.org\/10.1007\/s13346-023-01327-6","journal-title":"Drug Deliv Transl Res"},{"issue":"15","key":"1939_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512046","volume":"24","author":"O Urz\u00ec","year":"2023","unstructured":"Urz\u00ec O, Gasparro R, Costanzo E, De Luca A, Giavaresi G, Fontana S, Alessandro R (2023) Three-dimensional cell cultures: the bridge between in vitro and in vivo models. Int J Mol Sci 24(15):12046. https:\/\/doi.org\/10.3390\/ijms241512046","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1939_CR19","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1152\/physiol.00036.2016","volume":"32","author":"K Duval","year":"2017","unstructured":"Duval K, Grover H, Han LH, Mou Y, Pegoraro AF, Fredberg J, Chen Z (2017) Modeling physiological events in 2D vs. 3D cell culture. Physiology (Bethesda) 32(4):266\u2013277. https:\/\/doi.org\/10.1152\/physiol.00036.2016","journal-title":"Physiology (Bethesda)"},{"issue":"4","key":"1939_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.slasd.2023.03.006","volume":"28","author":"SY Lee","year":"2023","unstructured":"Lee SY, Koo IS, Hwang HJ, Lee DW (2023) In vitro three-dimensional (3D) cell culture tools for spheroid and organoid models. SLAS Discov 28(4):119\u2013137. https:\/\/doi.org\/10.1016\/j.slasd.2023.03.006","journal-title":"SLAS Discov"},{"key":"1939_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114816","volume":"196","author":"A Perez-Lopez","year":"2023","unstructured":"Perez-Lopez A, Torres-Suarez AI, Martin-Sabroso C, Aparicio-Blanco J (2023) An overview of in vitro 3D models of the blood-brain barrier as a tool to predict the in vivo permeability of nanomedicines. Adv Drug Deliv Rev 196:114816. https:\/\/doi.org\/10.1016\/j.addr.2023.114816","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"1939_CR22","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1177\/1087057117696795","volume":"22","author":"Y Fang","year":"2017","unstructured":"Fang Y, Eglen RM (2017) Three-dimensional cell cultures in drug discovery and development. SLAS Discov 22(5):456\u2013472. https:\/\/doi.org\/10.1177\/1087057117696795","journal-title":"SLAS Discov"},{"issue":"1","key":"1939_CR23","doi-asserted-by":"publisher","first-page":"9766","DOI":"10.1038\/s41598-020-66487-8","volume":"10","author":"G Nzou","year":"2020","unstructured":"Nzou G, Wicks RT, VanOstrand NR, Mekky GA, Seale SA, El-Taibany A, Wicks EE, Nechtman CM, Marrotte EJ, Makani VS, Murphy SV, Seeds MC, Jackson JD, Atala AJ (2020) Multicellular 3D neurovascular unit model for assessing hypoxia and neuroinflammation induced blood-brain barrier dysfunction. Sci Rep 10(1):9766. https:\/\/doi.org\/10.1038\/s41598-020-66487-8","journal-title":"Sci Rep"},{"key":"1939_CR24","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/srep01500","volume":"3","author":"E Urich","year":"2013","unstructured":"Urich E, Patsch C, Aigner S, Graf M, Iacone R, Freskgard PO (2013) Multicellular self-assembled spheroidal model of the blood brain barrier. Sci Rep 3:1500. https:\/\/doi.org\/10.1038\/srep01500","journal-title":"Sci Rep"},{"key":"1939_CR25","doi-asserted-by":"publisher","first-page":"15623","DOI":"10.1038\/ncomms15623","volume":"8","author":"CF Cho","year":"2017","unstructured":"Cho CF, Wolfe JM, Fadzen CM, Calligaris D, Hornburg K, Chiocca EA, Agar NYR, Pentelute BL, Lawler SE (2017) Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents. Nat Commun 8:15623. https:\/\/doi.org\/10.1038\/ncomms15623","journal-title":"Nat Commun"},{"key":"1939_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118743","volume":"336","author":"Q Li","year":"2025","unstructured":"Li Q, Sheng J, Baruscotti M, Liu Z, Wang Y, Zhao L (2025) Identification of Senkyunolide I as a novel modulator of hepatic steatosis and PPAR\u03b1 signaling in zebrafish and hamster models. J Ethnopharmacol 336:118743. https:\/\/doi.org\/10.1016\/j.jep.2024.118743","journal-title":"J Ethnopharmacol"},{"issue":"10","key":"1939_CR27","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.16438\/j.0513-4870.2021-1871","volume":"57","author":"HY Du","year":"2022","unstructured":"Du HY, Xue ZF, Xia ZT, He S, Yang J, Zhu Y (2022) Construction of 3D blood-brain barrier organoid oxygen-glucose deprivation model and exploration of the protective effect of Guanxinning injection. Acta Pharmaceutica Sinica 57(10):3086\u20133094. https:\/\/doi.org\/10.16438\/j.0513-4870.2021-1871","journal-title":"Acta Pharmaceutica Sinica"},{"issue":"8","key":"1939_CR28","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1021\/acsbiomaterials.1c00406","volume":"7","author":"E Ko","year":"2021","unstructured":"Ko E, Poon MLS, Park E, Cho Y, Shin JH (2021) Engineering 3D cortical spheroids for an in vitro ischemic stroke model. ACS Biomater Sci Eng 7(8):3845\u20133860. https:\/\/doi.org\/10.1021\/acsbiomaterials.1c00406","journal-title":"ACS Biomater Sci Eng"},{"issue":"7","key":"1939_CR29","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1248\/bpb.b21-00218","volume":"44","author":"K Kitamura","year":"2021","unstructured":"Kitamura K, Umehara K, Ito R, Yamaura Y, Komori T, Morio H, Akita H, Furihata T (2021) Development, characterization and potential applications of a multicellular spheroidal human blood-brain barrier model integrating three conditionally immortalized cell lines. Biol Pharm Bull 44(7):984\u2013991. https:\/\/doi.org\/10.1248\/bpb.b21-00218","journal-title":"Biol Pharm Bull"},{"key":"1939_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.622787","volume":"11","author":"J Li","year":"2021","unstructured":"Li J, Liu H, Yang Z, Yu Q, Zhao L, Wang Y (2021) Synergistic effects of cryptotanshinone and senkyunolide I in Guanxinning tablet against endogenous thrombus formation in zebrafish. Front Pharmacol 11:622787. https:\/\/doi.org\/10.3389\/fphar.2020.622787","journal-title":"Front Pharmacol"},{"issue":"1","key":"1939_CR31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1177\/0271678X15624933","volume":"37","author":"P Barteczek","year":"2017","unstructured":"Barteczek P, Li L, Ernst AS, Bohler LI, Marti HH, Kunze R (2017) Neuronal HIF-1\u03b1 and HIF-2\u03b1 deficiency improves neuronal survival and sensorimotor function in the early acute phase after ischemic stroke. J Cereb Blood Flow Metab 37(1):291\u2013306. https:\/\/doi.org\/10.1177\/0271678X15624933","journal-title":"J Cereb Blood Flow Metab"},{"key":"1939_CR32","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fncel.2018.00288","volume":"12","author":"Y Shen","year":"2018","unstructured":"Shen Y, Gu J, Liu Z, Xu C, Qian S, Zhang X, Zhou B, Guan Q, Sun Y, Wang Y, Jin X (2018) Inhibition of HIF-1\u03b1 reduced blood brain barrier damage by regulating MMP-2 and VEGF during acute cerebral ischemia. Front Cell Neurosci 12:288. https:\/\/doi.org\/10.3389\/fncel.2018.00288","journal-title":"Front Cell Neurosci"},{"key":"1939_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116186","volume":"228","author":"JJ Lochhead","year":"2024","unstructured":"Lochhead JJ, Ronaldson PT, Davis TP (2024) The role of oxidative stress in blood-brain barrier disruption during ischemic stroke: antioxidants in clinical trials. Biochem Pharmacol 228:116186. https:\/\/doi.org\/10.1016\/j.bcp.2024.116186","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"1939_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11101966","volume":"11","author":"MS Hernandes","year":"2022","unstructured":"Hernandes MS, Xu Q, Griendling KK (2022) Role of NADPH oxidases in blood-brain barrier disruption and ischemic stroke. Antioxidants 11(10):1966. https:\/\/doi.org\/10.3390\/antiox11101966","journal-title":"Antioxidants"},{"key":"1939_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2019.104370","volume":"139","author":"G Carota","year":"2019","unstructured":"Carota G, Raffaele M, Sorrenti V, Salerno L, Pittala V, Intagliata S (2019) Ginseng and heme oxygenase-1: the link between an old herb and a new protective system. Fitoterapia 139:104370. https:\/\/doi.org\/10.1016\/j.fitote.2019.104370","journal-title":"Fitoterapia"},{"issue":"1","key":"1939_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010014","volume":"23","author":"A Jurcau","year":"2021","unstructured":"Jurcau A, Simion A (2021) Neuroinflammation in cerebral ischemia and ischemia\/reperfusion injuries: from pathophysiology to therapeutic strategies. Int J Mol Sci 23(1):14. https:\/\/doi.org\/10.3390\/ijms23010014","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1939_CR37","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.2174\/1570159X18666200528143301","volume":"18","author":"T Okada","year":"2020","unstructured":"Okada T, Suzuki H, Travis ZD, Zhang JH (2020) The stroke-induced blood-brain barrier disruption: current progress of inspection technique, mechanism, and therapeutic target. Curr Neuropharmacol 18(12):1187\u20131212. https:\/\/doi.org\/10.2174\/1570159X18666200528143301","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"1939_CR38","doi-asserted-by":"publisher","first-page":"C343","DOI":"10.1152\/ajpcell.00095.2018","volume":"315","author":"W Abdullahi","year":"2018","unstructured":"Abdullahi W, Tripathi D, Ronaldson PT (2018) Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection. Am J Physiol Cell Physiol 315(3):C343\u2013C356. https:\/\/doi.org\/10.1152\/ajpcell.00095.2018","journal-title":"Am J Physiol Cell Physiol"},{"issue":"14","key":"1939_CR39","doi-asserted-by":"publisher","first-page":"7129","DOI":"10.1073\/pnas.1820799116","volume":"116","author":"AI Casas","year":"2019","unstructured":"Casas AI, Hassan AA, Larsen SJ, Gomez-Rangel V, Elbatreek M, Kleikers PWM, Guney E, Egea J, L\u00f3pez MG, Baumbach J, Schmidt HHHW (2019) From single drug targets to synergistic network pharmacology in ischemic stroke. Proc Natl Acad Sci U S A 116(14):7129\u20137136. https:\/\/doi.org\/10.1073\/pnas.1820799116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1939_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113859","volume":"176","author":"AS Hanafy","year":"2021","unstructured":"Hanafy AS, Dietrich D, Fricker G, Lamprecht A (2021) Blood-brain barrier models: rationale for selection. Adv Drug Deliv Rev 176:113859. https:\/\/doi.org\/10.1016\/j.addr.2021.113859","journal-title":"Adv Drug Deliv Rev"},{"key":"1939_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154609","volume":"109","author":"DL Hao","year":"2023","unstructured":"Hao DL, Li JM, Xie R, Huo HR, Xiong XJ, Sui F, Wang PQ (2023) The role of traditional herbal medicine for ischemic stroke: from bench to clinic-a critical review. Phytomedicine 109:154609. https:\/\/doi.org\/10.1016\/j.phymed.2022.154609","journal-title":"Phytomedicine"},{"key":"1939_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.05.028","volume":"214","author":"S Jackson","year":"2019","unstructured":"Jackson S, Meeks C, V\u00e9zina A, Robey RW, Tanner K, Gottesman MM (2019) Model systems for studying the blood-brain barrier: applications and challenges. Biomaterials 214:119217. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.05.028","journal-title":"Biomaterials"},{"key":"1939_CR43","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fnmol.2018.00166","volume":"11","author":"S Veszelka","year":"2018","unstructured":"Veszelka S, Toth A, Walter FR, Toth AE, Grof I, Meszaros M, Bocsik A, Hellinger E, Vastag M, Rakhely G, Deli MA (2018) Comparison of a rat primary cell-based blood-brain barrier model with epithelial and brain endothelial cell lines: gene expression and drug transport. Front Mol Neurosci 11:166. https:\/\/doi.org\/10.3389\/fnmol.2018.00166","journal-title":"Front Mol Neurosci"},{"key":"1939_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jconrel.2022.01.011","volume":"343","author":"E Jagtiani","year":"2022","unstructured":"Jagtiani E, Yeolekar M, Naik S, Patravale V (2022) In vitro blood brain barrier models: an overview. J Control Release 343:13\u201330. https:\/\/doi.org\/10.1016\/j.jconrel.2022.01.011","journal-title":"J Control Release"},{"key":"1939_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-1-0716-2289-6_2","volume":"2492","author":"S Raut","year":"2022","unstructured":"Raut S, Bhalerao A, Noorani B, Cucullo L (2022) In vitro models of the blood-brain barrier. Methods Mol Biol 2492:25\u201349. https:\/\/doi.org\/10.1007\/978-1-0716-2289-6_2","journal-title":"Methods Mol Biol"},{"issue":"1","key":"1939_CR46","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1038\/s41598-023-50203-3","volume":"14","author":"AN Paranjape","year":"2024","unstructured":"Paranjape AN, D\u2019Aiuto L, Zheng W, Chen X, Villanueva FS (2024) A multicellular brain spheroid model for studying the mechanisms and bioeffects of ultrasound-enhanced drug penetration beyond the blood-brain barrier. Sci Rep 14(1):1909. https:\/\/doi.org\/10.1038\/s41598-023-50203-3","journal-title":"Sci Rep"},{"key":"1939_CR47","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.actbio.2020.04.023","volume":"111","author":"V Sokolova","year":"2020","unstructured":"Sokolova V, Nzou G, van der Meer SB, Ruks T, Heggen M, Loza K, Hagemann N, Murke F, Giebel B, Hermann DM, Atala AJ, Epple M (2020) Ultrasmall gold nanoparticles (2 nm) can penetrate and enter cell nuclei in an in vitro 3D brain spheroid model. Acta Biomater 111:349\u2013362. https:\/\/doi.org\/10.1016\/j.actbio.2020.04.023","journal-title":"Acta Biomater"},{"issue":"15","key":"1939_CR48","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.4465","volume":"12","author":"R Isogai","year":"2022","unstructured":"Isogai R, Morio H, Okamoto A, Kitamura K, Furihata T (2022) Generation of a human conditionally immortalized cell-based multicellular spheroidal blood-brain barrier model for permeability evaluation of macromolecules. Bio-Protoc 12(15):e4465. https:\/\/doi.org\/10.21769\/BioProtoc.4465","journal-title":"Bio-Protoc"},{"issue":"8","key":"1939_CR49","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1021\/acs.molpharmaceut.2c00120","volume":"19","author":"K Kitamura","year":"2022","unstructured":"Kitamura K, Okamoto A, Morio H, Isogai R, Ito R, Yamaura Y, Izumi S, Komori T, Ito S, Ohtsuki S, Akita H, Furihata T (2022) Human immortalized cell-based blood-brain barrier spheroid models offer an evaluation tool for the brain penetration properties of macromolecules. Mol Pharm 19(8):2754\u20132764. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.2c00120","journal-title":"Mol Pharm"},{"issue":"1","key":"1939_CR50","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.1038\/s41598-018-25603-5","volume":"8","author":"G Nzou","year":"2018","unstructured":"Nzou G, Wicks RT, Wicks EE, Seale SA, Sane CH, Chen A, Murphy SV, Jackson JD, Atala AJ (2018) Human cortex spheroid with a functional blood brain barrier for high-throughput neurotoxicity screening and disease modeling. Sci Rep 8(1):7413. https:\/\/doi.org\/10.1038\/s41598-018-25603-5","journal-title":"Sci Rep"},{"issue":"11","key":"1939_CR51","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.4155\/fmc-2016-0025","volume":"8","author":"SJ Warchal","year":"2016","unstructured":"Warchal SJ, Unciti-Broceta A, Carragher NO (2016) Next-generation phenotypic screening. Future Med Chem 8(11):1331\u20131347. https:\/\/doi.org\/10.4155\/fmc-2016-0025","journal-title":"Future Med Chem"},{"issue":"7","key":"1939_CR52","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1177\/2472555220929291","volume":"25","author":"J Wardwell-Swanson","year":"2020","unstructured":"Wardwell-Swanson J, Suzuki M, Dowell KG, Bieri M, Thoma EC, Agarkova I, Chiovaro F, Strebel S, Buschmann N, Greve F, Frey O (2020) A framework for optimizing high-content imaging of 3D models for drug discovery. SLAS Discov 25(7):709\u2013722. https:\/\/doi.org\/10.1177\/2472555220929291","journal-title":"SLAS Discov"},{"issue":"5","key":"1939_CR53","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1517\/17460441.2016.1165203","volume":"11","author":"I Fraietta","year":"2016","unstructured":"Fraietta I, Gasparri F (2016) The development of high-content screening (HCS) technology and its importance to drug discovery. Expert Opin Drug Discov 11(5):501\u2013514. https:\/\/doi.org\/10.1517\/17460441.2016.1165203","journal-title":"Expert Opin Drug Discov"},{"issue":"4","key":"1939_CR54","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.3892\/etm.2019.7859","volume":"18","author":"J Liu","year":"2019","unstructured":"Liu J, Jiang Y, Zhang G, Lin Z, Du S (2019) Protective effect of edaravone on blood-brain barrier by affecting NRF-2\/HO-1 signaling pathway. Exp Ther Med 18(4):2437\u20132442. https:\/\/doi.org\/10.3892\/etm.2019.7859","journal-title":"Exp Ther Med"},{"issue":"3","key":"1939_CR55","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.jep.2013.12.027","volume":"151","author":"K Wu","year":"2014","unstructured":"Wu K, Wang ZZ, Liu D, Qi XR (2014) Pharmacokinetics, brain distribution, release and blood-brain barrier transport of Shunaoxin pills. J Ethnopharmacol 151(3):1133\u20131140. https:\/\/doi.org\/10.1016\/j.jep.2013.12.027","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"1939_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105507","volume":"30","author":"S Kale","year":"2021","unstructured":"Kale S, Sarode LP, Kharat A, Ambulkar S, Prakash A, Sakharkar AJ, Ugale RR (2021) Protocatechuic acid prevents early hour ischemic reperfusion brain damage by restoring imbalance of neuronal cell death and survival proteins. J Stroke Cerebrovasc Dis 30(2):105507. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.105507","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1939_CR57","doi-asserted-by":"publisher","first-page":"1278036","DOI":"10.3389\/fphar.2023.1278036","volume":"14","author":"J Wang","year":"2023","unstructured":"Wang J, Tang M, Xie X, Xu Y, Su P, Jin Z (2023) Efficacy of ferulic acid in the treatment of acute ischemic stroke injury in rats: a systematic review and meta-analysis. Front Pharmacol 14:1278036. https:\/\/doi.org\/10.3389\/fphar.2023.1278036","journal-title":"Front Pharmacol"},{"issue":"8","key":"1939_CR58","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.3390\/molecules28083636","volume":"28","author":"Y Huang","year":"2023","unstructured":"Huang Y, Wu Y, Yin H, Du L, Chen C (2023) Senkyunolide I: a review of its phytochemistry, pharmacology, pharmacokinetics, and drug-likeness. Molecules 28(8):3636. https:\/\/doi.org\/10.3390\/molecules28083636","journal-title":"Molecules"},{"issue":"5","key":"1939_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19051420","volume":"19","author":"AR Kho","year":"2018","unstructured":"Kho AR, Choi BY, Lee SH, Hong DK, Lee SH, Jeong JH, Park KH, Song HK, Choi HC, Suh SW (2018) Effects of protocatechuic acid (PCA) on global cerebral ischemia-induced hippocampal neuronal death. Int J Mol Sci 19(5):1420. https:\/\/doi.org\/10.3390\/ijms19051420","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1939_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11122377","volume":"11","author":"L Wang","year":"2022","unstructured":"Wang L, Zhang X, Xiong X, Zhu H, Chen R, Zhang S, Chen G, Jian Z (2022) Nrf2 regulates oxidative stress and its role in cerebral ischemic stroke. Antioxidants (Basel) 11(12):2377. https:\/\/doi.org\/10.3390\/antiox11122377","journal-title":"Antioxidants (Basel)"},{"issue":"18","key":"1939_CR61","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1097\/WNR.0000000000001542","volume":"31","author":"Z Xi","year":"2020","unstructured":"Xi Z, Chen X, Xu C, Wang B, Zhong Z, Sun Q, Sun Y, Bian L (2020) Protocatechuic acid attenuates brain edema and blood-brain barrier disruption after intracerebral hemorrhage in mice by promoting Nrf2\/HO-1 pathway. NeuroReport 31(18):1274\u20131282. https:\/\/doi.org\/10.1097\/WNR.0000000000001542","journal-title":"NeuroReport"},{"key":"1939_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2016.00056","volume":"10","author":"RJ Turner","year":"2016","unstructured":"Turner RJ, Sharp FR (2016) Implications of MMP9 for blood brain barrier disruption and hemorrhagic transformation following ischemic stroke. Front Cell Neurosci 10:56. https:\/\/doi.org\/10.3389\/fncel.2016.00056","journal-title":"Front Cell Neurosci"},{"key":"1939_CR63","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/124614","volume":"2013","author":"Y Wang","year":"2013","unstructured":"Wang Y, Ge P, Zhu Y (2013) TLR2 and TLR4 in the brain injury caused by cerebral ischemia and reperfusion. Mediators Inflamm 2013:124614. https:\/\/doi.org\/10.1155\/2013\/124614","journal-title":"Mediators Inflamm"},{"key":"1939_CR64","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.brainresbull.2018.11.006","volume":"144","author":"Y Li","year":"2019","unstructured":"Li Y, Zhong W, Jiang Z, Tang X (2019) New progress in the approaches for blood-brain barrier protection in acute ischemic stroke. Brain Res Bull 144:46\u201357. https:\/\/doi.org\/10.1016\/j.brainresbull.2018.11.006","journal-title":"Brain Res Bull"}],"container-title":["Journal of Natural Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-025-01939-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11418-025-01939-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-025-01939-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:38:00Z","timestamp":1756903080000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11418-025-01939-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1939"],"URL":"https:\/\/doi.org\/10.1007\/s11418-025-01939-x","relation":{},"ISSN":["1340-3443","1861-0293"],"issn-type":[{"value":"1340-3443","type":"print"},{"value":"1861-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,9]]},"assertion":[{"value":"8 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests regarding the publication of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}